<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.1" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
  <titleInfo>
    <title>Neuroimmune pharmacology</title>
  </titleInfo>
  <name type="personal">
    <namePart>Ikezu, Tsuneya</namePart>
  </name>
  <name type="personal">
    <namePart>Gendleman, Howard E.</namePart>
  </name>
  <typeOfResource>text</typeOfResource>
  <originInfo>
    <place>
      <placeTerm type="code" authority="marccountry">xxu</placeTerm>
    </place>
    <place>
      <placeTerm type="text">New York</placeTerm>
    </place>
    <publisher>Springer</publisher>
    <dateIssued>2008</dateIssued>
    <issuance>monographic</issuance>
  </originInfo>
  <language>
    <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
  </language>
  <physicalDescription>
    <form authority="marcform">print</form>
    <extent>xlix, 827 p. : ill. (some col) ; 1 CD [inside back cover]</extent>
  </physicalDescription>
  <tableOfContents>Contents: Introducing neoroimmune pharmacology --   Part 1: Immunology of he nervous system: Innate and adaptive immunity in health and disease -- Anatomical networks-structure and function of the nervous system -- The blood brain barrier --Anterior chamber and retina -- Hippocampus and spatial memory -- Glial and neuronal cellular composition, biology, and physiology -- Astrocytes, oligodendrocytes, and schwann cells -- Macrophages, microglia, and dendritic cells -- Neuronal and glial signaling -- The vertebrate retina -- Lymphocytes and the nervous system -- STem cells --Neurobiology and neural systems -- Cytokines and chemokines -- CNS cell signaling --   Part 2: Nervous system diseases and immunity- clinicaldescriptions -- Multiple sclerosis and other demyelinating deisease --   Guillain-Barre syndrome, Chronic inflammatory demyelinating polyradiculoneuropathy, and axonal degeneration and regeneration -- Guillain-Barre syndrome -- Autoimmune disease -- NueroAIDS --HTLV-I/II -- Viral encephalitis -- Alzheimer's disease -- Parkinson's disease -- Amyotrophic lateral sclerosis -- Huntingson's disease -- Prion diseases -- Glaucoma -- Sroke and cerebrovacular diesease -- Neurogenesis and brain repair -- Familail neurodegenerative diseases and single nucleotide polymorphisms -- The neuroimmune system in psychiatric disorders -- Major depression, bipolar syndromes, and schizophrenia -- Molecular pathogenesis for schizophrenia and major depression -- Drugs of abuse and the immune system --   Part 3: Therapeutics  Neuropharmacology -- Neurodegenerative diseases -- Multiple sclerosis -- Immuniotherapy -- Alzhemimer's disease -- Parkinson's disease and amyotrohic lateral sclerosis -- Protective and regenerative autoimmunity in CNS injury -- Adjuvants -- Polymer nanometerials --Gene therapy and vaccciantion -- Proteomics and genomics -- Neuroimaging -- </tableOfContents>
  <note type="statement of responsibility">Edited by Tsuneya Ikezu and Howard E. Gendleman</note>
  <note>Includes glossary and index.</note>
  <subject authority="lcsh">
    <topic>Pharmacology</topic>
  </subject>
  <subject authority="lcsh">
    <topic>Immunology</topic>
  </subject>
  <subject authority="mesh">
    <topic>Neuroscience</topic>
  </subject>
  <classification authority="lcc">RM315.N49</classification>
  <identifier type="isbn">9780387725727</identifier>
  <recordInfo>
    <recordCreationDate encoding="marc">150929</recordCreationDate>
    <recordChangeDate encoding="iso8601">20210414114650.0</recordChangeDate>
  </recordInfo>
</mods>
